There’s an opportunity to widen the therapeutic window of T-cell engagers by reducing cytokine release. See data on our CD3 x PSMA program at Festival of Biologics on April 15 - 17 to learn more. #FOBUSA
AbCellera’s Post
More Relevant Posts
-
Read this publication to get a practical blueprint for your biologics developability workflow. You’ll find an overview of the 4 major properties of your protein therapeutics to characterize, and why measuring multiple parameters is important to move robust, quality lead candidates forward. See publication: https://ow.ly/7StW50QrQlG
To view or add a comment, sign in
-
Biotech & Nanotechnology Consultant l Biologicals Formulation | Biosimilars & Innovative Biopharmaceuticals | Antibodies | Bioprocess | DoE | PMO
Great practical guide for Biosimilars Development
Read this publication to get a practical blueprint for your biologics developability workflow. You’ll find an overview of the 4 major properties of your protein therapeutics to characterize, and why measuring multiple parameters is important to move robust, quality lead candidates forward. See publication: https://ow.ly/7StW50QrQlG
Blueprint for antibody biologics developability
To view or add a comment, sign in
-
This blueprint publication is a great practical guide for early development biologics scientists! It's full of tables that summarize the most important CQAs for biologics developability, how to measure them, and the acceptable range/values for each related parameters. #antibodydiscovery #drugdevelopment
Read this publication to get a practical blueprint for your biologics developability workflow. You’ll find an overview of the 4 major properties of your protein therapeutics to characterize, and why measuring multiple parameters is important to move robust, quality lead candidates forward. See publication: https://ow.ly/7StW50QrQlG
Blueprint for antibody biologics developability
To view or add a comment, sign in
-
When you have an anomalous lab result, you just might be in trouble. However, Christina Vessely from Biologics Consulting can help you close the case of what went wrong, help you find a way to save the day, and help keep you from getting in trouble in the first place. 🎙️ Take a listen on this episode of Insight at Biologics: https://lnkd.in/gXA6DZrA
To view or add a comment, sign in
-
In BioPharm International's latest issue, our VP of Cell Line Development (CLD), Simon Keen, shares innovative approaches that can optimize cell line development for next-generation biologics. From vector construction to rapid cloning strategies, he provides insights on how to build a flexible and efficient CLD platform that reduces the potential for bottlenecks in the development pathway. "Efficient and flexible cell line development (CLD) platforms are critical to meeting the growing global demand for biologics." says Simon Keen. Dive into the full article to explore these advancements in detail: https://lnkd.in/epHXRy3d #CDMO #CRO #Celllinedevelopment #DrugDevelopment
To view or add a comment, sign in
-
Want to develop a smart HCP strategy? This series gives a solid overview of HCP analysis in biologics development, ways to ensure security of supply for critical reagents and, approaches for validating HCP ELISAs. https://cytiva.link/djrb8 #Hostcellprotein
Host Cell Protein Analysis in Biologics Development
cytiva.link
To view or add a comment, sign in
-
Don't miss our insightful webinar on "How to Optimize Stable Cell Line Manufacturing," presented by Renata Pankiewicz! ⏰ Mark your calendar - it starts in less than an hour! If you haven't registered yet, there are still some spots available at: https://bit.ly/CDD_webinar
Mark your calendars! We are partnering with Sphere Fluidics Limited and SelectScience® to present an exclusive webinar on "How to Optimize Stable Cell Line Manufacturing". Join us on May 23, as Renata Pankiewicz, Cell Line Development Lead for Antibody Manufacturing at FairJourney Biologics, shares invaluable insights to streamline your antibody process. Learn more and save your spot at: https://bit.ly/CDD_webinar
To view or add a comment, sign in
-
Dermatologist l Researcher l Educator Assistant Clinical Professor of Dermatology Yale University, Associate Director of Clinical Trials CCD Research, Partner at Central CT Dermatology
#Itch is by far the most significant issue our patients with #atopicdermatitis struggle with. It can impact #sleep, #workproductivity, and overall #qualityoflife. If you’re itching to know how to treat pruritus in your atopic dermatitis patients and stop the itch that rashes, tune into this CME discussion with Dr Susan Taylor, Dr Joshua Zeichner, and myself, as we explore how biologics can help soothe the itch associated with AD. #pruritus #biologics #patientreportedoutcomes Dermsquared
Explore the latest insights on pruritus from experts Drs. Taylor, Zeichner, and Shahriari. These experts share the latest information about atopic dermatitis management with biologics. To learn more, and start activity, click the link below. https://lnkd.in/e3ks8Cc2
To view or add a comment, sign in
-
Explore the latest insights on pruritus from experts Drs. Taylor, Zeichner, and Shahriari. These experts share the latest information about atopic dermatitis management with biologics. To learn more, and start activity, click the link below. https://lnkd.in/e3ks8Cc2
To view or add a comment, sign in
34,792 followers